Gurupartap Singh Sachdeva was named CEO of Jubilant Pharma, a wholly-owned subsidiary of Jubilant Life Sciences. He will be based in the US and have the overall responsibility for operations and report to the Jubilant Pharma Board. Prior to joining Jubilant, he was the President at Sun Pharmaceuticals.

Read the Economic Times news report here.